WO2000060953A2 - Methods for stabilizing liquid nutritional products and products so stabilized - Google Patents

Methods for stabilizing liquid nutritional products and products so stabilized Download PDF

Info

Publication number
WO2000060953A2
WO2000060953A2 PCT/EP2000/003504 EP0003504W WO0060953A2 WO 2000060953 A2 WO2000060953 A2 WO 2000060953A2 EP 0003504 W EP0003504 W EP 0003504W WO 0060953 A2 WO0060953 A2 WO 0060953A2
Authority
WO
WIPO (PCT)
Prior art keywords
nutritional product
guar gum
approximately
product
high amylose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/003504
Other languages
English (en)
French (fr)
Other versions
WO2000060953A3 (en
Inventor
Eileen C. Fuchs
Chandrasekhara Reddy Mallangi
Kjerstin Carlsson
Axel Syrbe
Reinhard Behringer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2369175A priority Critical patent/CA2369175C/en
Priority to JP2000610303A priority patent/JP5464681B2/ja
Priority to US09/959,131 priority patent/US7084107B1/en
Priority to MXPA01010278A priority patent/MXPA01010278A/es
Priority to IL14585800A priority patent/IL145858A0/xx
Priority to DE60027746T priority patent/DE60027746T2/de
Priority to BRPI0009728-4B1A priority patent/BR0009728B1/pt
Priority to NZ514685A priority patent/NZ514685A/en
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Priority to AU55232/00A priority patent/AU767090B2/en
Priority to EP00940230A priority patent/EP1225809B1/en
Publication of WO2000060953A2 publication Critical patent/WO2000060953A2/en
Priority to IL145858A priority patent/IL145858A/en
Anticipated expiration legal-status Critical
Publication of WO2000060953A3 publication Critical patent/WO2000060953A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/23—Carbon containing

Definitions

  • the present invention relates generally to the treatment of patients and products for treating patients. More specifically, the present invention relates to enteral solutions for providing nutritional support to patients.
  • Parenteral nutrition solutions include solutions that are infused intravenously into the patient through an IN system.
  • Enteral products include products that are fed into a patient's gastrointestinal system typically through a nasogastric feeding tube.
  • enteral nutritional support There are a variety of different products that have been designed to provide enteral nutritional support to a patient. Some of these products are designed to provide all necessary nutrients. On the other hand, a number of the enteral products can also be used as supplements to a normal diet. Some of these products are directed to specific disease states while other products are more generic and broad based for providing nutritional support to patients who cannot obtain necessary nutrients through traditional means of eating food.
  • the formulation may change. For example, certain patient populations may require increased protein levels. Likewise, certain patient populations may require hydrolyzed or non intact protein.
  • Nutritional enteral products include: Glytrol®; NutriHep®; NutriVent®; Probalance®; RenalCal®; Crucial®; Peptamen®; Peptamen VHP®; NuBasics®; NuBasics VHP®; Entrition®; Nutren®; Reablian®; Reablian HN®; Replete®; Travasorb®; Peptamen Jr.®; and Elementra®, all available from Nestle Clinical Nutrition, Deerfield, Illinois.
  • enteral nutrition products including Ross Laboratories a division of Abbott Laboratories, Mead Johnson, and Novartis.
  • C0NFIRMATI0N COPY instability reduces the product's elegance. Further, it may create an adverse impression in the minds of some consumers regarding the product's quality and acceptability, even though such serum separation does not adversely affect the quality or efficacy of the product.
  • the present invention provides methods for stabilizing nutritional products including enteral solutions. Additionally, the present invention provides solutions so stabilized.
  • the present invention provides an enteral formula comprising a protein source, a lipid source, and carbohydrates including high amylose starch and guar gum.
  • the protein source comprises approximately 10% to about 25% of the total calories.
  • the lipid source comprises approximately 25% to about 50% of the total calories.
  • carbohydrates comprise approximately 40% to about 60% of the total calories.
  • the high amylose starch comprises at least approximately 50% amylose.
  • high amylose starch and guar gum as a total comprise approximately 2.25% to about 7.5% of the total caloric content.
  • high amylose starch comprises approximately 2% to about 6.5% of the total caloric content.
  • the product includes xanthan.
  • guar gum comprises 0.25% to about 1.0% of the total caloric content.
  • the weight ratio of high amylose starch to guar gum is approximately 2.5:1 to 16:1.
  • the product includes carrageenan.
  • the present invention provides an enteral product comprising a hydrolyzed whey protein source, a source of lipids, and a sufficient amount of a stabilizer to prevent serum separation, the stabilizer including high amylose starch and guar gum.
  • the protein source comprises approximately 10% to about 25% of the total calories.
  • the lipid source comprises approximately 25% to about 50% of the total calories.
  • high amylose starch and guar gum as a total comprise approximately 2.25% to about 7.50% of the total caloric content.
  • high amylose starch comprises approximately 2.0% to about 6.5% of the total caloric content.
  • guar gum comprises 0.25% to about 1.0% of the total caloric content.
  • the weight ratio of high amylose starch to guar gum is approximately 2.5:1 to 16:1.
  • the source of lipids includes medium and long chain triglycerides.
  • the product at 1500 Kcal provides at least 100% of the U.S. RDA of vitamins and minerals.
  • the product has a caloric content of approximately 1.0 Kcal/ml.
  • a method of stabilizing an enteral solution comprises the step of adding to an enteral solution a stabilizing amount of high amylose starch and guar gum.
  • an advantage of the present intention is to provide nutritional products including enteral solutions having greater stability.
  • a further advantage of the present invention is to provide a stabilizer system for nutritional products.
  • an advantage of the present invention is to provide nutritional products that have improved compatibility of ingredients, especially starches and gums. Further, an advantage of the present invention is to provide an enteral solution including hydrolyzed whey protein having a stabilizing combination of starch and gum.
  • an advantage of the present invention is to provide methods of stabilizing enteral solutions.
  • an advantage of the present invention is to provide improved enteral solutions.
  • an advantage of the present invention is to substantially reduce if not eliminate serum separation in enteral products.
  • Another advantage of the present invention is to provide a method for stabilizing starch and gum combinations.
  • Figure 1 illustrates graphically the effect of starch and gum on viscosity and sediment pursuant to Example No. 1.
  • Figure 2 illustrates graphically viscosity of products during storage pursuant to
  • the present invention provides methods for stabilizing nutritional products including enteral solutions. Additionally, the present invention provides nutritional products including enteral solutions so stabilized.
  • the use of high amylose starch and guar gum stabilizes enteral products, especially those containing hydrolyzed protein.
  • the high amylose starch comprises at least approximately 50% amylose, and most preferably approximately 70% amylose.
  • the high amylose starch and guar gum as a combination comprises approximately 2.25% to about 7.5% of the caloric content of the product.
  • the weight ratio of high amylose starch to guar gum is approximately 2.5:1 to 16:1; and more preferably approximately 8:1 to about 12:1.
  • high amylose starch comprises approximately 2.0% to 6.5% of the caloric content of the product.
  • guar gum comprises approximately 0.25% to about 1.0% of the caloric content of the product.
  • the product will include in addition to the stabilizing system of high amylose starch and guar gum a protein source, a lipid source, vitamins and minerals.
  • the protein source will comprise approximately 10% to about 25%, and more preferably approximately 12% to about 20%, of the caloric content of the product.
  • the protein is hydrolyzed protein such as hydrolyzed whey or hydrolyzed casein.
  • the lipid source will comprise approximately 25% to about 50%, and more preferably approximately 30% to about 40%, of the caloric content of the product.
  • the lipids are a mixture of long chain triglycerides (LCTS) and medium chain triglycerides (MCTS).
  • the carbohydrate source will comprise approximately 40% to about 60%, and more preferably approximately 45% to 55%, of the caloric content of the product.
  • the product will provide at least 100% of the U.S. RDA of vitamins and minerals in 1500 Kcal of product (1500 mis).
  • an example of the present invention is as follows: Nutrient _ Amount % U.S. RDA*
  • Peptamen® is a hydrolyzed whey protein based enteral solution which is manufactured by a UHT process and aseptically filled into cans and aseptic pouches. Serum separation has been observed in some Peptamen® products. The serum usually develops within 2 weeks and develops more rapidly at cooler temperatures (40°F and 72°F) than at elevated temperatures (86°F and 100°F).
  • the starches included Melojel (low amylose starch) (25% amylose from National Starch) and Eurylon 7 (high amylose starch) (70% amylose from Roquette).
  • the gums evaluated included guar gum as well as xanthan gum (Keltrol SF).
  • a 50:50 blend of Xanthan gum and guar gum was also evaluated.
  • a blend of iota and kappa carrageenans was also evaluated to determine its effect on serum separation.
  • the variables were put into storage at 40°F, 72°F, 86°F and 100°F conditions and were evaluated on 2 week intervals for serum separation and viscosity change.
  • fresh samples were transferred from the cans into sterile jars and stored at ambient temperature for visual inspection of the samples.
  • the control samples containing Melojel starch and guar gum had serum in the top layer as occurs in some such commercial batches.
  • the formulas containing Eurylon 7 starch and guar gum had the least or no serum development compared to those con1---ining Melojel starch.
  • the amount of separation was similar in the samples containing guar or xanthan gum in combination with the Melojel starch.
  • Formulas without guar gum added had lower viscosity and greater salt sediment compared to formulas containing gum which had higher viscosity.
  • the variable with Eurylon 7 starch alone had slightly smaller amount of sediment than Melojel (low amylose) starch alone.
  • Carrageenan added to the Melojel starch formula increased the viscosity slightly and reduced the sediment slightly. However, the sediment was still visible and significantly more than samples containing the Melojel starch and guar gum.
  • Eurylon 7 starch is more stable and does not develop serum at all the tested storage conditions as does Melojel starch.
  • the Melojel starch/guar gum/carrageenan variable which is stable at ambient temperature for 3 months had some serum separation at 40°F, however it is significantly less than without the added carrageenan (50 mis vs 150 mis).
  • the viscosity of the Eurylon 7 does not change significantly during storage at both 72°F and 100°F conditions (See Figure 2).
  • the Eurylon 7 variables also exhibited less viscosity change at 100°F than the Melojel Starch.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • General Preparation And Processing Of Foods (AREA)
PCT/EP2000/003504 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized Ceased WO2000060953A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
BRPI0009728-4B1A BR0009728B1 (pt) 1999-04-14 2000-04-13 produtos nutricionais e métodos para estabilização de uma solução entérica
US09/959,131 US7084107B1 (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized
MXPA01010278A MXPA01010278A (es) 1999-04-14 2000-04-13 Metodo para estabilizar productos nutricionales liquidos y productos estabilizados de esta manera.
IL14585800A IL145858A0 (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized
DE60027746T DE60027746T2 (de) 1999-04-14 2000-04-13 Verfahren zur stabilisierung von flüssigen nahrungsprodukten und stabilisierte nahrungsprodukte
NZ514685A NZ514685A (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized
AU55232/00A AU767090B2 (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized
CA2369175A CA2369175C (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized
JP2000610303A JP5464681B2 (ja) 1999-04-14 2000-04-13 液体栄養製品の安定化方法および安定化製品
EP00940230A EP1225809B1 (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized
IL145858A IL145858A (en) 1999-04-14 2001-10-10 Methods for stabilizing liquid nutritional products and products so stabilized

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/291,830 US6355609B1 (en) 1999-04-14 1999-04-14 Methods for stabilizing liquid nutritional products and products so stabilized
US09/291,830 1999-04-14

Publications (2)

Publication Number Publication Date
WO2000060953A2 true WO2000060953A2 (en) 2000-10-19
WO2000060953A3 WO2000060953A3 (en) 2002-05-30

Family

ID=23122033

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/003504 Ceased WO2000060953A2 (en) 1999-04-14 2000-04-13 Methods for stabilizing liquid nutritional products and products so stabilized

Country Status (15)

Country Link
US (2) US6355609B1 (https=)
EP (1) EP1225809B1 (https=)
JP (2) JP5464681B2 (https=)
CN (1) CN1184903C (https=)
AT (1) ATE324799T1 (https=)
AU (1) AU767090B2 (https=)
BR (1) BR0009728B1 (https=)
CA (1) CA2369175C (https=)
DE (1) DE60027746T2 (https=)
ES (1) ES2262521T3 (https=)
IL (2) IL145858A0 (https=)
MX (1) MXPA01010278A (https=)
NZ (1) NZ514685A (https=)
WO (1) WO2000060953A2 (https=)
ZA (1) ZA200107921B (https=)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008046870A1 (en) * 2006-10-19 2008-04-24 Nestec S.A. Long-term feed - cancer patient
WO2008046865A3 (en) * 2006-10-19 2008-12-11 Nestec Sa Long-term feed - elderly
WO2012117065A1 (en) * 2011-03-01 2012-09-07 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
EP1800663A4 (en) * 2004-10-12 2012-12-05 Meiji Co Ltd ENTERALER FOOD
WO2013087916A1 (en) * 2011-12-15 2013-06-20 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
WO2013101400A1 (en) * 2011-12-30 2013-07-04 Abbott Laboratories Stabilized nutritional compositions including starch
US8530447B2 (en) 2005-10-24 2013-09-10 Nestec S.A. Dietary fiber formulation and method of administration

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355609B1 (en) * 1999-04-14 2002-03-12 Nestec S.A. Methods for stabilizing liquid nutritional products and products so stabilized
US20030194468A1 (en) * 2002-04-12 2003-10-16 Amy Konkoly Dairy beverage and method of preparation thereof
GB0213612D0 (en) * 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
CN101511206B (zh) 2006-07-13 2013-07-17 雀巢产品技术援助有限公司 用于液体营养组合物的稳定剂系统
BR112012009487A2 (pt) * 2009-10-26 2017-05-09 Nestec Sa formulações de espessante estáveis
JP6104647B2 (ja) * 2013-03-07 2017-03-29 三栄源エフ・エフ・アイ株式会社 半固形化流動食又は栄養剤
CN106974265A (zh) * 2016-01-19 2017-07-25 江苏恒瑞医药股份有限公司 一种肠内营养组合物
CN117752089A (zh) * 2023-08-16 2024-03-26 江苏西宏生物医药有限公司 一种适用于限制脂肪摄入的液体流质制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3343966A (en) * 1963-11-20 1967-09-26 Crest Foods Co Inc Stabilizer composition and method of incorporating a stabilizer gum into a food mix
US3950547A (en) 1974-08-26 1976-04-13 Syntex (U.S.A.) Inc. Dietary composition and methods of preparing
FR2518372B2 (fr) 1981-12-23 1986-05-09 Hygiene Nutritionnelle Composition alimentaire, utile notamment pour les diabetiques, et son application dans le traitement des troubles du metabolisme glucidique
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
JP2735559B2 (ja) * 1988-03-02 1998-04-02 中外製薬株式会社 懸濁液
JPH0451870A (ja) 1990-06-14 1992-02-20 Terumo Corp 抗肥満性食品およびその製造方法
US5215777A (en) * 1991-05-16 1993-06-01 Ault Foods Limited Process for producing low or non fat ice cream
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
CA2124405A1 (en) 1993-05-28 1994-11-29 David Yoder Caseinate replacement composition for imitation cheese
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5681600A (en) * 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
JP3639057B2 (ja) * 1996-08-05 2005-04-13 ミヨシ油脂株式会社 高周波トッピング用チーズ様乳化組成物
US5968586A (en) * 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses
US6355609B1 (en) * 1999-04-14 2002-03-12 Nestec S.A. Methods for stabilizing liquid nutritional products and products so stabilized

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1800663A4 (en) * 2004-10-12 2012-12-05 Meiji Co Ltd ENTERALER FOOD
US8530447B2 (en) 2005-10-24 2013-09-10 Nestec S.A. Dietary fiber formulation and method of administration
WO2008046865A3 (en) * 2006-10-19 2008-12-11 Nestec Sa Long-term feed - elderly
AU2007312216B2 (en) * 2006-10-19 2011-03-31 Nestec S.A. Long-term feed - cancer patient
WO2008046870A1 (en) * 2006-10-19 2008-04-24 Nestec S.A. Long-term feed - cancer patient
US11883370B2 (en) 2011-03-01 2024-01-30 Societe Des Produits Nestle S.A. Extensional viscosity to promote safe swallowing of food boluses
WO2012117065A1 (en) * 2011-03-01 2012-09-07 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
EP3005885A1 (en) * 2011-03-01 2016-04-13 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
US12290492B2 (en) 2011-03-01 2025-05-06 Societe Des Produits Nestle S.A. Extensional viscosity to promote safe swallowing of food boluses
US10583097B2 (en) 2011-03-01 2020-03-10 Societe Des Produits Nestle S.A. Extensional viscosity to promote safe swallowing of food boluses
WO2013087916A1 (en) * 2011-12-15 2013-06-20 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
WO2013101400A1 (en) * 2011-12-30 2013-07-04 Abbott Laboratories Stabilized nutritional compositions including starch
US9844227B2 (en) 2011-12-30 2017-12-19 Abbott Laboratories Stabilized nutritional compositions including starch

Also Published As

Publication number Publication date
JP5464681B2 (ja) 2014-04-09
US7084107B1 (en) 2006-08-01
BR0009728B1 (pt) 2013-08-27
DE60027746D1 (de) 2006-06-08
ATE324799T1 (de) 2006-06-15
CN1184903C (zh) 2005-01-19
EP1225809B1 (en) 2006-05-03
ES2262521T3 (es) 2006-12-01
CA2369175C (en) 2011-01-25
WO2000060953A3 (en) 2002-05-30
AU5523200A (en) 2000-11-14
EP1225809A2 (en) 2002-07-31
DE60027746T2 (de) 2007-04-26
MXPA01010278A (es) 2002-03-27
CA2369175A1 (en) 2000-10-19
JP2011012078A (ja) 2011-01-20
BR0009728A (pt) 2002-01-02
ZA200107921B (en) 2003-03-26
CN1374838A (zh) 2002-10-16
JP5441267B2 (ja) 2014-03-12
JP2003517456A (ja) 2003-05-27
IL145858A (en) 2006-07-05
AU767090B2 (en) 2003-10-30
US6355609B1 (en) 2002-03-12
IL145858A0 (en) 2002-07-25
NZ514685A (en) 2003-09-26

Similar Documents

Publication Publication Date Title
AU742545B2 (en) Nutritional product for a person having renal failure
CA2684929C (en) Acidified liquid human milk supplement
CA2369175C (en) Methods for stabilizing liquid nutritional products and products so stabilized
JP6076741B2 (ja) 無菌包装されているｈｍｂを含む栄養液
WO2006112998A1 (en) Liquid nutritional product to supplement human milk
EP2242383B1 (en) Induced viscosity nutritional emulsions comprising a carbohydrate-surfactant complex
KR101397863B1 (ko) 고농도의 나트륨을 함유한 액상 영양 조성물 및 그의 제조 방법
EP3771342A1 (en) A drinkable dairy product for pregnant and lactating women
CN116349875A (zh) 一种口服全营养组合物及其制备方法
HK1142239B (en) Acidified liquid human milk supplement

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00806203.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 514685

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/010278

Country of ref document: MX

Ref document number: IN/PCT/2001/1406/CHE

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2369175

Country of ref document: CA

Ref document number: 2369175

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 610303

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 55232/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000940230

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09959131

Country of ref document: US

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000940230

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 55232/00

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2000940230

Country of ref document: EP